FIELD: medicine, pharmaceutical industry. SUBSTANCE: invention relates to medicinal forms containing recombinant interferon and used for prophylaxis and treatment of viral diseases. An antiviral agent comprises recombinant alpha-, beta- or gamma-interferon, immunomodulating agent, antibacterial agent and/or anti- inflammatory preparation, stabilizing agent and pharmaceutically acceptable special additions. The agent is made as a liquid or soft, or solid medicinal form. EFFECT: expanded assortment of antiviral medicinal agents. 19 cl, 9 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| CURATIVE AGENT | 2000 | 
 | RU2187332C1 | 
| CONDOM LUBRICANT | 2000 | 
 | RU2187329C1 | 
| ANTIVIRAL, ANTIBACTERIAL AND ANTICANDIDOSIS AGENT | 2000 | 
 | RU2187328C1 | 
| ANTIVIRUS MEANS IN LIPOSOME FORM | 2000 | 
 | RU2176518C1 | 
| RECOMBINANT INTERFERON-BASE ANTIVIRAL AGENT AS OINTMENT, SUPPOSITORY, CREAM, LINIMENT | 1999 | 
 | RU2150291C1 | 
| MEDICINAL PREPARATION | 2000 | 
 | RU2187331C1 | 
| MEDICINAL PREPARATION FOR PROPHYLAXIS AND TREATMENT OF INFECTIOUS DISEASES | 2001 | 
 | RU2185840C1 | 
| INTRANASAL AGENT | 2002 | 
 | RU2220739C1 | 
| DRUG HERPFERON-2 POSSESSING ANTIVIRAL, ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANALGESIC ACTION FOR LOCAL AND EXTERNAL APPLICATION | 2012 | 
 | RU2488405C1 | 
| ANTIVIRAL MEDICATION - NASAL DROPS | 2010 | 
 | RU2437676C1 | 
Authors
Dates
2002-08-20—Published
2000-12-18—Filed